How allergens trigger asthma attacks

March 19, 2018, CNRS
How allergens trigger asthma attacks
Excessive mucus production is characteristic of allergic asthma. The IL-33 protein, a major factor predisposing humans to asthma, detects allergen protease activity. Activated by proteases, IL-33 sets off a cascade of reactions, including mucus production, that are associated with asthma and other allergic diseases. When IL-33 activation is inhibited (see image on right), these reactions are not triggered. Credit: Corinne Cayrol and Jean-Philippe Girard, IPBS, CNRS / Université Toulouse III--Paul Sabatier

A team of Inserm and CNRS researchers from the Institute of Pharmacology and Structural Biology have identified a protein that acts like a sensor detecting allergens in the respiratory tract that are responsible for asthma attacks. Their study, co-directed by Corinne Cayrol and Jean-Philippe Girard, is published in Nature Immunology. The work offers hope for breakthroughs in the treatment of allergic diseases.

What do mold, pollen, and cockroaches have in common? Though they correspond to three different kingdoms of life, they can all cause in susceptible people. And all of them, despite their very different compositions, contain enzymes called proteases.

The IPBS team has identified a human protein that reacts to : interleukin-33 (IL-33). When allergens enter the human , they release proteases that hack IL-33 molecules into extremely reactive pieces, triggering the chain reactions behind allergy symptoms.

Apparently, the same mechanism is responsible for these reactions after exposure to any of several allergens. IL-33 was shown to detect 14 different allergens tested, which include some present in ambient air (i.e. pollen, house dust mites, and fungal spores) and others associated with occupational asthma (like subtilisin, found in detergents).

These findings are important because they establish a direct link between genetics and the environment. Indeed, the gene that codes for IL-33 is among the principal ones predisposing humans to asthma. Furthermore, clinical trials now underway are targeting IL-33. Inhibiting production of reactive IL-33 fragments after exposure might make it possible to limit severe allergic reactions in asthmatic patients.

Explore further: Research reveals possible new treatment pathway for severe allergic asthma

More information: Corinne Cayrol et al, Environmental allergens induce allergic inflammation through proteolytic maturation of IL-33, Nature Immunology (2018). DOI: 10.1038/s41590-018-0067-5

Related Stories

Research reveals possible new treatment pathway for severe allergic asthma

October 13, 2017
Research demonstrates that blocking the action of two pro-inflammatory molecules significantly reduces symptoms of allergic asthma in mice, which could lead to development of a new treatment for people with a severe form ...

Schools environment associated with asthma symptoms

November 21, 2016
Do air-borne allergens in schools affect students' asthma symptoms?

Researchers discover receptor that protects against allergies, asthma

February 26, 2018
A special receptor on cells that line the sinuses, throat and lungs evolved to protect mammals from developing a range of allergies and asthma, according to a study from researchers at Johns Hopkins Bloomberg School of Public ...

Key step in allergic reactions revealed

October 14, 2014
By studying the mode of action of the interleukin-33 protein, an alarmin for white blood cells, a team at the Institut de Pharmacologie et de Biologie Structurale (IPBS - CNRS/Université Toulouse III - Paul Sabatier) has ...

New approach to predict respiratory allergy in early childhood

December 4, 2017
A new study in EBioMedicine by researchers at Karolinska Institutet in Sweden and the Medical University of Vienna, Austria suggests that immune response in early childhood to a handful of allergen molecules can predict the ...

Basophils are found to be key drivers of allergy-induced lung inflammation

July 25, 2014
Many particles and molecules in the environment can trigger allergic asthma in susceptible individuals. The allergic response to some of these allergens results in lung inflammation that can lead to a narrowing of the airways ...

Recommended for you

New findings suggest allergic responses may protect against skin cancer

July 17, 2018
The components of the immune system that trigger allergic reactions may also help protect the skin against cancer, suggest new findings.

The immune system: T cells are built for speed

July 17, 2018
Without T cells, we could not survive. They are a key component of the immune system and have highly sensitive receptors on their surface that can detect pathogens. The exact way that these receptors are distributed over ...

Broadly acting antibodies found in plasma of Ebola survivors

July 17, 2018
Recent Ebola virus disease (EVD) outbreaks, including the 2013-2016 epidemic that ravaged West Africa and the 2018 outbreak in the Democratic Republic of the Congo, highlight the need for licensed treatments for this often-deadly ...

How protein fragments could help to tackle the cause of hay fever

July 16, 2018
Imperial researchers are looking to protein fragments to help people build up resistance to grass pollen.

Team explores diabetes drug's ability to treat RSV infection

July 13, 2018
A drug used to treat diabetes may point to new therapies for respiratory syncytial virus (RSV) bronchiolitis—inflammation and obstruction of the lungs' small airways. A multi-disciplinary team of Vanderbilt investigators ...

Testing suggests TORC1 inhibitors can boost immune system in the elderly

July 12, 2018
A team of researchers affiliated with Novartis Institutes for Biomedical Research and Biometrics Matters Limited, has found via testing with volunteers that TORC1 inhibitors can boost the immune system in the elderly. In ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.